Parion Sciences: Durham-based Parion licenses potential dry-eye drug, could earn $535M
Durham-based Parion Sciences has granted exclusive worldwide development and commercialization rights to its potential therapy for dry eye disease to Shire, a global pharmaceutical company.
Read full article »
Parion Sciences is a pharmaceutical firm that engages in discovery and development of new treatments for serious diseases.
Read more